A VEGF-dependent gene signature enriched in mesenchymal ovarian cancer predicts patient prognosis.
about
The Prognostic 97 Chemoresponse Gene Signature in Ovarian Cancer.Identification of Pharmacologically Tractable Protein Complexes in Cancer Using the R-Based Network Clustering and Visualization Program MCODER.Recommendations for biomarker testing in epithelial ovarian cancer: a National Consensus Statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology.FSH receptor binding inhibitor impacts K-Ras and c-Myc of ovarian cancer and signal pathway.
P2860
A VEGF-dependent gene signature enriched in mesenchymal ovarian cancer predicts patient prognosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A VEGF-dependent gene signatur ...... er predicts patient prognosis.
@en
A VEGF-dependent gene signatur ...... er predicts patient prognosis.
@nl
type
label
A VEGF-dependent gene signatur ...... er predicts patient prognosis.
@en
A VEGF-dependent gene signatur ...... er predicts patient prognosis.
@nl
prefLabel
A VEGF-dependent gene signatur ...... er predicts patient prognosis.
@en
A VEGF-dependent gene signatur ...... er predicts patient prognosis.
@nl
P2093
P2860
P356
P1433
P1476
A VEGF-dependent gene signatur ...... cer predicts patient prognosis
@en
P2093
Boqiang Shen
Hongxia Li
Mei-Chun Cai
Xiaojie Wang
Zhenfeng Zhang
P2860
P2888
P356
10.1038/SREP31079
P407
P577
2016-08-08T00:00:00Z